Twin Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,933
| Closed | -$1.18M | – | 322 |
|
|
2024
Q4 | $1.18M | Sell |
2,933
-2,826
| -49% | -$1.14M | 0.13% | 154 |
|
|
2024
Q3 | $2.68M | Sell |
5,759
-135
| -2% | -$62.8K | 0.3% | 94 |
|
|
2024
Q2 | $2.76M | Buy |
5,894
+30
| +0.5% | +$14.1K | 0.33% | 81 |
|
|
2024
Q1 | $2.45M | Sell |
5,864
-328
| -5% | -$137K | 0.3% | 99 |
|
|
2023
Q4 | $2.52M | Sell |
6,192
-162
| -3% | -$65.9K | 0.33% | 92 |
|
|
2023
Q3 | $2.21M | Sell |
6,354
-441
| -6% | -$153K | 0.32% | 93 |
|
|
2023
Q2 | $2.39M | Sell |
6,795
-262
| -4% | -$92.2K | 0.31% | 96 |
|
|
2023
Q1 | $2.22M | Sell |
7,057
-3,564
| -34% | -$1.12M | 0.3% | 103 |
|
|
2022
Q4 | $3.07M | Sell |
10,621
-33
| -0.3% | -$9.53K | 0.4% | 76 |
|
|
2022
Q3 | $3.09M | Sell |
10,654
-70
| -0.7% | -$20.3K | 0.42% | 66 |
|
|
2022
Q2 | $3.02M | Buy |
10,724
+4,235
| +65% | +$1.19M | 0.39% | 80 |
|
|
2022
Q1 | $1.69M | Buy |
6,489
+85
| +1% | +$22.2K | 0.18% | 151 |
|
|
2021
Q4 | $1.41M | Buy |
6,404
+1,229
| +24% | +$270K | 0.14% | 169 |
|
|
2021
Q3 | $939K | Buy |
+5,175
| New | +$939K | 0.1% | 203 |
|
|
2019
Q1 | – | Sell |
-11,770
| Closed | -$1.95M | – | 278 |
|
|
2018
Q4 | $1.95M | Sell |
11,770
-33,450
| -74% | -$5.54M | 0.11% | 207 |
|
|
2018
Q3 | $8.72M | Buy |
45,220
+1,450
| +3% | +$279K | 0.4% | 74 |
|
|
2018
Q2 | $7.44M | Buy |
43,770
+300
| +0.7% | +$51K | 0.37% | 89 |
|
|
2018
Q1 | $7.09M | Buy |
43,470
+24,720
| +132% | +$4.03M | 0.37% | 90 |
|
|
2017
Q4 | $2.81M | Buy |
+18,750
| New | +$2.81M | 0.14% | 191 |
|